HIV Treatment and Care Research priorities
7
HIV Treatment and Care Research priorities • Facilitator – Dr Saphonn Vonthanak • 12 participants • 29 agreed topics – not grouped on methodology or subject category • 3 scoring categories – Importance – Urgency – Feasibility • Short group discussion to clarify each topic • Each participant invited to give score out of 5 for each topic in each category • Mean score calculated for each topic in each category • Summary score for each topic
description
HIV Treatment and Care Research priorities. Facilitator – Dr Saphonn Vonthanak 12 participants 29 agreed topics not grouped on methodology or subject category 3 scoring categories Importance Urgency Feasibility Short group discussion to clarify each topic - PowerPoint PPT Presentation
Transcript of HIV Treatment and Care Research priorities
HIV Treatment and Care Research priorities
• Facilitator – Dr Saphonn Vonthanak• 12 participants• 29 agreed topics
– not grouped on methodology or subject category• 3 scoring categories
– Importance– Urgency– Feasibility
• Short group discussion to clarify each topic• Each participant invited to give score out of 5 for each
topic in each category• Mean score calculated for each topic in each category• Summary score for each topic
Topics (1 – 15)
1 Sequencing 1st , 2nd, 3rd line ART
2 Viral load testing strategies
3 Drug resistance
4 Adherence over long term
5 Drug resistance
6 Appropriateness of current ART protocols to Cambodian population
7 Drug resistance
8
Management of HIV co infection (esp children) (TB, hepatitis, Cryptococcus Meningitis ..)
9 Co management of related diseases (hepatitis B, diabetes..) - health system
10 Neurological manifestations (adult and children)
11 Psychiatric / depression
12
Stigma and discrimination of health care professionals+ community: impact on testing / treatments/ adherence
13 Barriers to HIV testing and care of women not classified as high risk
14 Barriers to HIV testing and care of children < 2 years (laboratory)
15 Barriers to HIV testing and care of children (general)
Topics (16 – 29)
16
Barriers to HIV testing and care among particular populations (particular populations sex workers, IDU..)
17 Poverty / transportation effect on care and treatment / outcomes
18
Health system strengthening + integration of HIV care and treatment into mainstream health services
19 Feasibility of integration of HIV care package into insurance package
20 HEF and health insurance and access to HIV care
21 Costing 2nd line regimens
22 Post exposure prophylaxis availability / behaviors
23 Impact of HIV infected status on household
24 Cost effectiveness including quality of life, with without treatment
25 Mother to child transmission rate (with and without ART intervention)
26 Ways to improve uptake of pregnant women to testing and care
27 HIV health care delivery options (Human Resources)
28
Prevention among positive
29
Home based care role in the continuum of careHIV and nutrition
Importance – top 11
1 Adherence over long term 5.0
2 Viral load testing strategies (best testing strategy- timing) 4.8
3 Sequencing 1st , 2nd,… line ART 4.5
4
Stigma and discrimination of health care professionals/ community and impact on testing / treatments/ adherence 4.4
5 Management of HIV co infection (esp children) (TB, hepatitis, Crypto M…..) 4.3
6 Barriers of access to testing and care among particular pop (SW, IDU..) 4.2
7 Barriers to HIV testing and care of women (not classified as high risk group) 4.2
8 Poverty / transportation effect on care and treatment 4.2
9 Ways to improve uptake of pregnant women to testing and care 4.2
10 Cost effectiveness analysis including QOL of PLHA with, without treatment 4.1
11 HEF and health insurance and access to HIV/AIDS care 4.1
Urgency – top 10
1 Adherence over long term 4.9
2 Viral load testing strategies (best testing strategy- timing) 4.8
3 Psychiatric / depression 4.2
4 Barrier of access to testing and care among particular pop (SW, IDU..) 4.1
5 Sequencing 1st , 2nd, 3rd line ART 4.1
6 Management of HIV co infection (esp children) (TB, hepatitis, Crypto M…) 4.1
7 Prevention among positive “positive prevention” 3.8
8 short and long term toxicities associated with current protocols 3.7
9 Barriers to HIV testing and care of women (not classified as high risk group) 3.7
10 Mother to child transmission rate (with and without ART intervention) 3.6
Feasibility – top 10
1 Adherence over long term 4.3
2Stigma and discrimination of health care professionals/ community and impact on testing / treatments/ adherence 4.1
3 Barriers to HIV testing and care of children 3.7
4 Role of Home based care in CoC 3.4
5 Cost effectiveness analysis including QOL of PLHA + /- ART 3.3
6 Barriers to HIV testing + care of women (not classified as high risk ) 3.2
7 Barrier of access to testing + care among particular pop (SW, IDU..) 3.1
8 Short and long term toxicities associated with current protocols 3.1
9 Prevention among positive 3.1
10 viral load testing strategies (best testing strategy- timing) 3.0
Combined – top 10
1 Adherence over long term 1702 Stigma and discrimination of health care professionals/ community and impact on testing / treatments/ adherence 1523 viral load testing strategies (best testing strategy- timing) 1504 Barriers to HIV testing and care of women (not classified as high risk group) 1325 sequencing 1st , 2nd, 3rd line ART 1316 short and long term toxicities associated with current protocols 1297 Prevention among positive 1298 Role of Home based care in CoC 1299 Barriers to HIV testing and care of children 128
10 Poverty / transportation effect on care and treatment 128
